Halina Machelska-Stein

Title: Halina Machelska-Stein: Inventor in Analgesic Nanocarrier Technology.

Introduction

Halina Machelska-Stein is an inventor associated with Berlin, Germany, and Dendropharm GmbH. Her work includes an invention in the field of analgesics that explores how nanocarriers may influence the effects of pain-relieving medicines.

Latest Patents

Machelska-Stein is associated with 1 patent, titled “Analgesic Preparation with Nanocarriers and Use Thereof.” The invention describes a pharmaceutical composition or kit combining a hyperbranched polymer nanocarrier, such as a dendritic polymer or dendrimer, with an analgesic that can have both peripheral and central effects when administered without a carrier. Nalbuphine is identified as a preferred example.

According to the patent description, the nanocarrier is intended to make the analgesic act mainly or exclusively in the periphery. This approach may reduce side effects associated with activating central or intestinal opioid receptors. The proposed use is the treatment of peripheral pain and inflammation.

Career Highlights

The available information connects Machelska-Stein’s patent work with Dendropharm GmbH and pharmaceutical research into nanocarrier-based analgesic preparations. The invention focuses on modifying where an analgesic exerts its effects, with the aim of supporting treatment of peripheral pain and inflammation.

Collaborations

Florian Paulus and Emanuel Fleige are identified as Machelska-Stein’s coworkers. Their names are associated with the professional context provided for her work.

Conclusion

Halina Machelska-Stein’s patent describes a nanocarrier-based approach to analgesia that aims to concentrate a medicine’s effects in peripheral tissues and potentially reduce certain side effects.